Dr. Poole is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4715 Arapahoe Ave
Boulder, CO 80303Phone+1 303-385-2000Fax+1 303-444-1839
Education & Training
- University of Utah HealthResidency, Internal Medicine, 2012 - 2015
- Wayne State University School of MedicineClass of 2012
- University of Utah HealthFellowship, Hematology and Medical Oncology
- Michigan State UniversityBS, Psychology, High Honors
Certifications & Licensure
- CO State Medical License 2018 - 2025
- UT State Medical License 2013 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsReal-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma.Xiting Cao, Derek H. Tang, Barbara Ratto, Austin Poole, Shoba Ravichandran
Clinical Genitourinary Cancer. 2020-02-01 - 8 citationsGermline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC)Andrew W. Hahn, David Gill, Austin Poole, Roberto Nussenzveig, Sara Wilson
Molecular Cancer Therapeutics. 2019-03-01 - 19 citationsGermline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate CancerAndrew W. Hahn, David Gill, Roberto Nussenzveig, Austin Poole, J. M. Farnham
Clinical Genitourinary Cancer. 2018-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: